
Episode: 47 - Curved Air and The Long Road To A Sickle Cell Cure
A cure can be real and still feel out of reach. Trends from the Trenches host Allison Proffitt is joined by Kevin Davies, executive editor of T he CRISPR Journal and author of Curved Air: A Biography of Sickle Cell Anemia and the Quest to Cure the First Molecular Disease. Kevin shares how sickle cell disease became both a landmark genetics story and a test of whether medicine can treat patients with dignity. He follows Victoria Gray’s CRISPR gene therapy success while facing the discrimination, underfunding, and access barriers that still shape sickle cell care. • Why Curved Air centers sickle cell warriors as the lead characters • Why gene therapy success does not erase racism and bias in emergency care • Stories of mistreatment during pain crises and the cost of lost trust • How sickle cell spread globally through malaria selection and migration • Why the first molecular disease took decades to reach curative treatment • Funding gaps compared with cystic fibrosis and what that changes • How hydroxyurea helps and why better everyday treatments still matter • What Casgevy demands from patients and why durability monitoring continues • Why affordability and infrastructure limit global access in Africa and India • What could come next with in vivo editing and small molecule BCL11A ideas LINKS https://www.bio-itworld.com/ https://www.bio-itworldexpo.com/ https://www.linkedin.com/company/bio-it-world https://twitter.com/bioitworld Host Links Allison Proffitt: https://www.linkedin.com/in/allison-proffitt-02138222 Guest Links Kevin Davies LinkedIn: https://www.linkedin.com/in/kevindaviesphd/ Curved Air (Amazon): https://www.amazon.com/Curved-Air-Biography-Molecular-Disease/dp/0674293967 Bio-IT World ’s Trends from the Trenches podcast delivers your insider’s look at the science, technology, and executive trends driving the life sciences through conversations with industry leaders.












